Clinical Trials Browser

Phase 1/2 × Lutetium-177 × Clear all

NCT05413850 2026-04-13

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Phase 1/2 Recruiting

Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT04261855 2026-03-27

GoTHAM

Phase 1/2 Active not recruiting

DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT06881823 2025-12-29

NeoPSMA

Phase 1/2 Withdrawn

Prostatic Neoplasms